Regulations.gov document
Reference 12 - U.S. Food and Drug Administration, "Guidance for industry, Considerations…
Supporting & Related Material · FDA-2006-N-0515 · posted Dec 5, 2014
Key facts
| Document ID | FDA-2006-N-0515-0081 |
|---|---|
| Title | Reference 12 - U.S. Food and Drug Administration, "Guidance for industry, Considerations for Developmental Toxicity Studies for Preventive and Therapeutic Vaccines for Infectious Disease Indications," 2006. re Content and Format of Labeling for Human Prescription Drug and Biological Products; Requirements for Pregnancy and Lactation Labeling |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2006-N-0515 |
| Posted | Dec 5, 2014 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: